BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37787316)

  • 1. Carcinoma cervix: A single institute experience from Kashmir, Northern India.
    Nasreen S; Lone AR; Manzoor A; Dar SA; Banday SZ; Nuzhatu N; Rasool MT; Andleeb A; Wani SQ; Fatima K; Sofi MA; Hussain S; Dar NA
    J Cancer Res Ther; 2023; 19(5):1407-1411. PubMed ID: 37787316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University.
    Serarslan A; Gursel B; Meydan D; Ozbek Okumus N
    BMC Cancer; 2019 Dec; 19(1):1208. PubMed ID: 31830953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix.
    Hashmi H; Maqbool A; Ahmed S; Ahmed A; Sheikh K; Ahmed A
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):302-5. PubMed ID: 27097702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation.
    Rose PG; Java JJ; Whitney CW; Stehman FB; Lanciano R; Thomas GM
    Gynecol Oncol; 2014 Nov; 135(2):208-12. PubMed ID: 25152438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
    Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
    JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locally advanced cervical cancer: A study of 5-year outcomes.
    Chopra S; Gupta M; Mathew A; Mahantshetty U; Engineer R; Lavanya G; Gupta S; Ghosh J; Thakur M; Deodhar K; Menon S; Rekhi B; Bajpai J; Gulia S; Maheshwari A; Kerkar R; Shylasree TS; Shrivastava SK
    Indian J Cancer; 2018; 55(1):45-49. PubMed ID: 30147092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
    Hu K; Wang W; Liu X; Meng Q; Zhang F
    Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?
    Caires IQ; Souza KT; Negrão MV; de Oliveira JA; Barroso-Sousa R; de Lima RC; Hoff PM; Diz Mdel P
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():86-9. PubMed ID: 26182837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of patients of cervical cancer a tertiary center in Bihar.
    Kumari A; Pankaj S; Choudhary V; Kumari A; Nazneen S; Kumari J; Kumar S
    Indian J Cancer; 2018; 55(1):70-73. PubMed ID: 30147097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in patients of carcinoma cervix Stage IIIB treated with definitive radiotherapy.
    Elizabeth NB; Malik M; Valiyaveettil D; Basalathullah MAR; Ahmed SF
    Cancer Treat Res Commun; 2021; 27():100365. PubMed ID: 33799003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma?
    Walji N; Chue AL; Yap C; Rogers LJ; El-Modir A; Chan KK; Singh K; Fernando IN
    Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):140-6. PubMed ID: 20045300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Huang YJ; Chanchien CC; Lin H; Wang CJ; Sun LM; Tseng CW; Tsai CC; Ou YC; Fu HC; Chen HC; Hsu HC; Wang CY
    Radiat Oncol; 2012 Jan; 7():13. PubMed ID: 22289572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy.
    Kise S; Arakaki Y; Kudaka W; Ariga T; Kinjo N; Kohatu H; Aoki Y
    Anticancer Res; 2022 Oct; 42(10):4887-4893. PubMed ID: 36191992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and Outcomes with Platinum-Based Chemotherapy in Recurrent or Metastatic Carcinoma Cervix in a Developing Country: Experience from a Tertiary Oncology Centre in Southern India.
    Lakshmaiah KC; Thanky AH; Lokanatha D; Govind Babu K; Jacob L; Babu S; Rudresha AH; Lokesh KN; Rajeev LK; Sridharmurthy A
    Gulf J Oncolog; 2017 Sep; 1(25):20-26. PubMed ID: 29019326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.